Table 2.
Baseline Characteristics of Primary Care Patients With Early Discontinuation or Persistence (≤90 days) of Glargine or NPH Basal Insulin Therapy (BOT).
| Variables | Glargine discontinuation | Glargine persistence | NPH discontinuation | NPH persistence | P valuea |
|---|---|---|---|---|---|
| N | 146 | 1342 | 146 | 1342 | |
| Age (years) | 60.5 (12.2) | 55.8 (11.6) | 60.7 (12.8) | 59.0 (11.8) | <.0001 |
| Diabetes duration (years) | 5.8 (3.8) | 6.5 (4.0) | 5.9 (3.1) | 5.5 (3.7) | <.0001 |
| Males (%) | 52.1 | 53.4 | 49.3 | 54.1 | .7045 |
| Region (western Germany) (%) | 78.8 | 70.0 | 77.4 | 79.0 | <.0001 |
| Diabetologist care (%) | 10.3 | 16.5 | 8.9 | 17.0 | .0165 |
| Disease management program (%) | 62.3 | 71.2 | 60.3 | 70.3 | .0086 |
| Number of different oral antidiabetic drugs (baseline) | 1.4 (0.5) | 1.4 (0.6) | 2.0 (1.2) | 1.4 (0.6) | .8393 |
| Last HbA1c (%) (baseline) | 8.8 (1.6) | 8.8 (1.6) | 8.5 (1.7) | 8.5 (1.6) | <.0001 |
| Charlson Comorbidity Index | 2.1 (1.4) | 2.1 (1.5) | 2.0 (1.2) | 2.0 (1.3) | .9098 |
Data are means (SD) or proportions (%).
a
P values for group differences (linear or logistic regression model).